Literature DB >> 17162212

Hepatic injury following reduced intensity unrelated cord blood transplantation for adult patients with hematological diseases.

Eiji Kusumi1, Masahiro Kami, Yoshinobu Kanda, Naoko Murashige, Kunihiko Seki, Masayo Fujiwara, Rikako Koyama, Tsunehiko Komatsu, Akiko Hori, Yuji Tanaka, Koichiro Yuji, Tomoko Matsumura, Kazuhiro Masuoka, Atsushi Wake, Shigesaburo Miyakoshi, Shuichi Taniguchi.   

Abstract

Liver injury is a common complication in allogeneic hematopoietic stem cell transplantation. Its major causes comprise graft-versus-host disease (GVHD), infection, and toxicities of preparative regimens and immunosuppressants; however, we have little information on liver injuries after reduced intensity cord blood transplantation (RICBT). We reviewed medical records of 104 recipients who underwent RICBT between March 2002 and May 2004 at Toranomon Hospital. Preparative regimen and GVHD prophylaxis comprised fludarabine/melphalan/total body irradiation and cyclosporine or tacrolimus. We assessed the etiology of liver injuries based on the clinical presentation, laboratory results, comorbid events, and imaging studies in 85 patients who achieved primary engraftment. The severity of liver dysfunction was assessed according to the National Cancer Institute Common Toxicity Criteria version 2.0. Hyperbilirubinemia was graded according to a report by Hogan et al (Blood. 2004;103:78-84). Moderate to very severe liver injuries were observed in 36 patients. Their causes included cholestatic liver disease (CLD) related to GVHD or sepsis (n = 15), GVHD (n = 7), cholangitis lenta (n = 5), and others (n = 9). Median onsets of CLD, GVHD, and cholangitis lenta were days 37, 40, and 22, respectively. Frequencies of grade 3-4 alanine aminotransferase elevation were comparable across the 3 types of hepatic injuries. Serum gamma-glutamil transpeptidase was not elevated in any patients with cholangitis lenta, whereas 27% and 40% of patients with CLD and GVHD, respectively, developed grade 3-4 gamma-glutamil transpeptidase elevation. Multivariate analysis identified 2 risk factors for hyperbilirubinemia; grade II-IV acute GVHD (relative risk, 2.23; 95% confidential interval, 1.11-4.47; P = .024) and blood stream infection (relative risk, 3.77; 95% confidential interval, 1.91-7.44; P = .00013). In conclusion, the present study has demonstrated that the hepatic injuries are significant problems after RICBT, and that GVHD and blood stream infection contribute to their pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17162212     DOI: 10.1016/j.bbmt.2006.07.013

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  2 in total

1.  Drug-induced liver injury after allogeneic bone marrow transplantation.

Authors:  Takayoshi Tachibana; Akito Nozaki; Makiko Enaka; Eri Yamamoto; Rika Kawasaki; Hideyuki Koharazawa; Maki Hagihara; Daisuke Ishibashi; Yuki Nakajima; Hideyuki Kuwabara; Naoto Tomita; Yoshiaki Ishigatsubo; Shin Fujisawa
Journal:  Int J Hematol       Date:  2013-09-15       Impact factor: 2.490

2.  High-density lipoprotein infusion protects from acute graft-versus-host disease in experimental allogeneic hematopoietic cell transplantation.

Authors:  Cécile Chagué; Thomas Gautier; Ludivine Dal Zuffo; Jean-Paul Pais de Barros; Audrey Wetzel; Georges Tarris; Gaëtan Pallot; Laurent Martin; Séverine Valmary-Degano; Valérie Deckert; Laurent Lagrost; Etienne Daguindau; Philippe Saas
Journal:  Am J Transplant       Date:  2022-02-10       Impact factor: 9.369

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.